Agreement is lacking - both across institutions and within departments - for the management of six commonly encountered incidental findings on body CT, concludes a study in the November issue of the Journal of the American College of Radiology. Departments should develop guidelines to ensure consistent patient recommendations, authors said.
Agreement is lacking - both across institutions and within departments - for the management of six commonly encountered incidental findings on body CT, concludes a study in the November issue of the Journal of the American College of Radiology. Departments should develop guidelines to ensure consistent patient recommendations, authors said.
A team led by radiologist Pamela T. Johnson, MD, of Johns Hopkins University, designed a multiple-choice survey to query radiologists about their handling of 12 incidental findings - something unrelated to the illness being treated and found by accident - on body CT.
Choices ranged from “do not report” to advising interventional procedures tailored to the organ. Surveys were administered to body CT attending radiologists at Johns Hopkins, New York University and Stanford University.
The hypothetical patient was a 45-year-old woman with no history of cancer. Johnson and colleagues included a 1-cm thyroid nodule, a 5-mm noncalcified lung nodule, coronary artery calcification, a 2-cm adrenal nodule, a 2-cm pancreatic cyst, a 1-cm enhancing liver lesion, a 2-cm high-density renal cyst, short-segment small bowel intussusception, a 1-cm splenic cyst, focal gallbladder wall calcification, and a 3-cm ovarian cyst in both a premenopausal woman and a postmenopausal woman.
The 27 radiologists who completed the survey came to 70 percent or greater agreement on interpretation for only six findings: recommend ultrasound for a 1-cm thyroid nodule, recommend ultrasound for a 3-cm cyst in postmenopausal woman, follow Fleischner Society recommendations for a 5-mm lung nodule, describe only coronary calcification, and describe as likely benign both short-segment small bowel intussusception and a 1-cm splenic cyst.
“It is important to note that at present, 100 percent agreement was not identified for the management of any of the 12 findings. An equally essential discovery is the lack of agreement across academic institutions and even within individual institutions for other incidental findings,” said Johnson.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.